NIKKEI 225
27,606.46 -79.01 (-0.29%) HANG SENG
21,283.52 -15.18 (-0.07%) CRUDE OIL
78.46 +1.32 (+1.71%) GOLD FUTURES
1,890.50 +5.70 (+0.30%) DOW
34,015.02 -141.67 (-0.41%) BTC-GBP
18,961.32 -81.20 (-0.43%)
Tandem Diabetes Care, Inc. (0M0F.L)
| Previous close | 41.03 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | N/A |
| Market cap | 2.514B |
| Beta (5Y monthly) | 0.97 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
2 Growth Stocks to Buy While They Are Still Down
With that in mind, let's look at two growth stocks that fit the bill: Tandem Diabetes Care (NASDAQ: TNDM) and Fiverr (NYSE: FVRR). Medical device specialist Tandem Diabetes Care focuses on the diabetes market, as its name suggests. The company has been an innovator in the field, and right now, it makes money by selling its prized insulin pump, the t:slim X2.
- Motley Fool
2 Stocks Down 72% or More to Buy in 2023 and Hold for 10 Years
For those who need inspiration, let's consider two stocks that have been trashed this year but still boast solid, long-term prospects: Tandem Diabetes Care (NASDAQ: TNDM) and Roku (NASDAQ: ROKU). In the next decade, Tandem Diabetes Care can count on its disruptive innovations and the increase in the number of diabetes patients to deliver outsize returns. The company's t:slim X2 insulin pump is much easier on people with diabetes than multiple daily injections (MDIs) and Tandem's product provides features that most don't offer, including continuous glucose monitoring integration to automate the insulin delivery system completely.
- Simply Wall St.
Is There An Opportunity With Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) 49% Undervaluation?
In this article we are going to estimate the intrinsic value of Tandem Diabetes Care, Inc. ( NASDAQ:TNDM ) by...
